Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML
Clinical trial NCT07026942 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07026942
- Sponsor
- Nationwide Children's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2032-07-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.